As the Myriad plaintiffs make their second attempt at Supreme Court review, uncertainty over US patent eligibility law is causing some to wonder whether industry or subject matter-specific standards should be imposed by courts. Eileen McDermott investigates
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
National groups for the UK and the Netherlands have flagged concerns with the choice of venue, following a formal complaint from Australia’s national group